Product
OMA
1 clinical trial
1 indication
Indication
AsthmaClinical trial
Impact of Omalizumab Withdrawal After a 3 Year Duration Treatment in Well Controlled Severe Allergic Asthma : a Multicentric Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2025-05-20